Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02560246 · ClinicalTrials.gov registry record
Maternal Gut Microbiome (MGM) Study of Diet, the Gut Microbiome and Preterm Birth
A clinical trial, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 400
- Enrollment target
NCT02560246: Completed study, sponsored by University of Pennsylvania.
NCT02560246 is a clinical trial that has completed, run by University of Pennsylvania. The registered enrollment target is 400 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02560246 has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 400 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether diet and the gut microbiome play a role in spontaneous preterm birth (SPTB), namely delivery of the fetus prior to 37 weeks gestation.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2015-05-04 |
| Est. Completion | 2017-08-29 |
What the finished NCT02560246 record still lists
NCT02560246 is an observational study that tracks outcomes without assigning an intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT02560246 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02560246 about?
NCT02560246 is a clinical study titled "Maternal Gut Microbiome (MGM) Study of Diet, the Gut Microbiome and Preterm Birth". The purpose of this study is to determine whether diet and the gut microbiome play a role in spontaneous preterm birth (SPTB), namely delivery of the fetus prior to 37 weeks gestation.
What is the current status of trial NCT02560246?
This trial is currently completed. The enrollment target is 400 participants. The study started on 2015-05-04. Estimated completion is 2017-08-29.
Who is sponsoring clinical trial NCT02560246?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
- NCT02216500 · 400 participants · NA
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
- NCT02250352 · 400 participants
Core Biopsies for Establishing a Breast Tumor Tissue Repository
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI